1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
Senate Bill 448
Sponsored by Senator PATTERSON (Presession filed.)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced.The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act would tell the OHA to study and report on a medical condition that causes
people to move when they take some types of medicine. (Flesch Readability Score: 60.0).
Requires the Oregon Health Authority to study medication-induced movement disorders and
submit a report to the interim committees of the Legislative Assembly related to public health and
health care no later than December 31, 2025.
Sunsets on January 2, 2026.
Takes effect on the 91st day following adjournment sine die.
A BILL FOR AN ACT
Relating to medication-induced movement disorders; and prescribing an effective date.
Be It Enacted by the People of the State of Oregon:
SECTION 1. (1) The Oregon Health Authority shall study and prepare a strategic plan for
the State of Oregon to address medication-induced movement disorders. The plan, at a min-
imum, must:
(a) Analyze existing resources and identify opportunities to expand existing resources for
medication-induced movement disorders for patients, providers and caregivers in this state.
(b) Develop, publish and distribute guidance and best practices for health care and mental
health professionals on screening, diagnosing and treating medication-induced movement
disorders in accordance with the document prepared by the Oregon Health Authority titled
“Recognition and Management of Antipsychotic-induced Movement Disorders,” dated April
2024.
(c) Develop recommendations to ensure minority populations have equitable access to
existing and expanded resources for medication-induced movement disorders for patients,
providers and caregivers in this state.
(d) Analyze how restrictions on the authority to prescribe medications have affected the
ability of behavioral health patients to be screened, diagnosed and treated for medication-
induced movement disorders.
(e) Develop educational materials for law enforcement and public safety professionals to
assist in recognizing and responding to medication-induced movement disorders.
(f) Explain how the authority will implement the opportunities identified in paragraph (a)
of this subsection and recommendations developed under paragraph (c) of this subsection.
(2) The authority shall submit a report on the strategic plan described in subsection (1)
of this section, in the manner provided by ORS 192.245, and may include recommendations
for legislation, to the interim committees of the Legislative Assembly related to public health
and health care no later than December 31, 2025.
SECTION 2. Section 1 of this 2025 Act is repealed on January 2, 2026.
NOTE:Matter in boldfaced type in an amended section is new; matter [italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 717 SB448
1
2
3
SECTION 3. This 2025 Act takes effect on the 91st day after the date on which the 2025
regular session of the Eighty-third Legislative Assembly adjourns sine die.
[2]